IBEX Technologies Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IBEX Technologies Inc with three other
miscellaneous service companies in North America:
Bioxyne Limited
of UNITED STATES
(2020
sales of $1.51 million
),
Applied Genetic Technologies Corp
of UNITED STATES
($2.45 million
of which 100%
was Gene therapy), and
Starpharma Holdings Limited
which is
also
based in UNITED STATES
($4.77 million
of which 100%
was endrimers for pharmaceutical).
Sales Analysis.
IBEX Technologies Inc reported sales of C$5.21 million (US$4.12 million)
for the
fiscal
year ending
July of 2020.
This
represents
an
increase of 20.9%
versus 2019, when the company's sales were C$4.31 million.